|
MPHOSPH10 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.95929955487873E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.9124999996516E-08 |
| Normal-vs-Stage2 |
8.09310000016161E-07 |
| Normal-vs-Stage3 |
4.98559971084944E-10 |
| Normal-vs-Stage4 |
8.09989997296867E-09 |
| Stage1-vs-Stage2 |
2.314400E-01 |
| Stage1-vs-Stage3 |
2.579700E-02 |
| Stage1-vs-Stage4 |
8.868100E-02 |
| Stage2-vs-Stage3 |
6.912600E-01 |
| Stage2-vs-Stage4 |
7.272800E-01 |
| Stage3-vs-Stage4 |
9.824400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.57209977947571E-10 |
| Normal-vs-AfricanAmerican |
1.60093000000083E-05 |
| Normal-vs-Asian |
2.10239999999251E-05 |
| Caucasian-vs-AfricanAmerican |
3.372800E-01 |
| Caucasian-vs-Asian |
4.055000E-01 |
| AfricanAmerican-vs-Asian |
1.434800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16879999515029E-08 |
| Normal-vs-Female |
1.14340004131464E-09 |
| Male-vs-Female |
9.361000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.14370000031872E-07 |
| Normal-vs-Age(41-60Yrs) |
1.11539999458898E-10 |
| Normal-vs-Age(61-80Yrs) |
1.68139999701111E-08 |
| Normal-vs-Age(81-100Yrs) |
3.438600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.531600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.848400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.040000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.562600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.426000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.633600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.859000E-03 |
| Classical-VS-Follicular |
2.268000E-02 |
| Classical-VS-Other |
9.191600E-01 |
| Classical-VS-Normal |
9.10799999864764E-08 |
| Tall-VS-Follicular |
4.396200E-01 |
| Tall-VS-Other |
1.684840E-01 |
| Tall-VS-Normal |
5.62459999686737E-08 |
| Follicular-VS-Other |
4.248800E-01 |
| Follicular-VS-Normal |
5.4926999948357E-08 |
| Other-VS-Normal |
6.454200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03479999516532E-09 |
| Normal-vs-N1 |
3.86439999999766E-05 |
| N0-vs-N1 |
3.664200E-01 |
|
|
